Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc. (MD)

Market Closed
17 Jul, 20:00
NYSE NYSE
$
26. 13
-0.21
-0.7973%
$
2.13B Market Cap
0 P/E Ratio
- Div Yield
566,400 Volume
1.24 Eps
$ 26.34
Previous Close
Add Transaction
Day Range
25.96 26.76
Year Range
11.84 27.94
Want to track MD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pediatrix Medical Group (MD) Q1 Earnings and Revenues Surpass Estimates

Pediatrix Medical Group (MD) Q1 Earnings and Revenues Surpass Estimates

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.33 per share a year ago.

Zacks | 2 months ago
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term

Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 months ago
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 months ago
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 months ago
Pediatrix Ties Up to Provide Better Maternal Care in Tennessee

Pediatrix Ties Up to Provide Better Maternal Care in Tennessee

MD expands maternal care in Tennessee through a new partnership, boosts high-risk pregnancy services and aims for immediate earnings accretion.

Zacks | 3 months ago
Here's Why Investors Continue to Hold Pediatrix Medical Stock

Here's Why Investors Continue to Hold Pediatrix Medical Stock

Favorable payer mix, higher neonatology acuity and prudent acquisitions will support MD's growth, while shares look undervalued versus industry peers.

Zacks | 4 months ago
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term

Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 4 months ago
Pediatrix Medical Q4 Earnings Miss Estimates Despite Declining Costs

Pediatrix Medical Q4 Earnings Miss Estimates Despite Declining Costs

MD's Q4 EPS miss estimates as revenues dip, but same-unit gains and a stronger 2026 EBITDA outlook signal mixed momentum.

Zacks | 4 months ago
Pediatrix Medical Group (MD) Q4 Earnings Lag Estimates

Pediatrix Medical Group (MD) Q4 Earnings Lag Estimates

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.5 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.51 per share a year ago.

Zacks | 4 months ago
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

MD is positioned for growth on stronger collections, payer mix and acquisitions, as shares jump 55.2% in six months, beating the industry's 6.7% gain.

Zacks | 6 months ago
Why Is Pediatrix Medical Group (MD) Up 11.1% Since Last Earnings Report?

Why Is Pediatrix Medical Group (MD) Up 11.1% Since Last Earnings Report?

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?

Zacks | 7 months ago
Pediatrix Medical Group, Inc. (MD) Hit a 52 Week High, Can the Run Continue?

Pediatrix Medical Group, Inc. (MD) Hit a 52 Week High, Can the Run Continue?

Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 7 months ago
Loading...
Load More